Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2005
09/14/2005EP1399157B1 Combination comprising a p-gp inhibitor and an anti-epileptic drug
09/14/2005EP1392643B1 Trisubstituted-n- (1s)-1,2,3,4-tetrahydro-1-naphthalenyl] benzamides which inhibit p2x3 and p2x2/3 containing receptors
09/14/2005EP1363651B1 Herbal compositions useful as chemopreventive and therapeutic agents
09/14/2005EP1284958B1 Method of inhibiting amyloid protein aggregation and imaging amyloid deposits using aminoidane derivatives
09/14/2005EP1258250B1 Nerve protective drugs
09/14/2005EP1200402B1 Substituted 1,5-dihydropyrrol-2-on derivatives as nmda receptor antagonists for the treatment of pain
09/14/2005EP1091737B1 Use of 1-(3,3-diphenylpropionyl)-4-benzhydril piperazine in the treatment of pain
09/14/2005EP0904283B1 Human netrin-1
09/14/2005EP0804437B1 [a]-ANNELATED PYRROLE DERIVATIVES AND PHARMACEUTICAL USES THEREOF
09/14/2005CN1668761A Therapeutic use of selective PDE10 inhibitors
09/14/2005CN1668728A A process for decreasing environmental pollutants in an oil or a fat, a volatile environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
09/14/2005CN1668721A Immunoadhesin comprising a glycoprotein VI domain
09/14/2005CN1668629A Modulation of the expression of genes dependent on STAT-1
09/14/2005CN1668628A Novel thiophene glycoside derivatives, processes for the preparation, medicaments comprising these compounds, and the use thereof
09/14/2005CN1668621A Diazabicyclononane and -decane derivatives and their use as opioid receptor ligands
09/14/2005CN1668620A 1-heterocyclylalkyl-3-sulfonylazaindole or -azaindazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668619A Imidazo[1, 2-a]pyrazin-8-ylamines, method of making and method of use thereof
09/14/2005CN1668617A Process for the preparation of imidazo(1, 2-A)pyridine-3-acetamides
09/14/2005CN1668615A Novel benzimidazole derivatives
09/14/2005CN1668614A Bicyclic piperidine derivatives as antagonists of the CCR1 chemokine receptor
09/14/2005CN1668611A 1-[(indol-3-yl)carbonyl] piperazine derivatives
09/14/2005CN1668602A 6-amino-1H-indazole and 4-aminobenzofuran compounds as phosphodiesterase 4 inhibitors
09/14/2005CN1668592A Piperidine derivatives and their use as selective inhibitors of MIP-1alpha binding to its receptor CCR1
09/14/2005CN1668590A 1-heterocyclylalkyl-3-sulfonyl-indole or -indazole derivatives as 5-hydroxytryptamine-6 ligands
09/14/2005CN1668589A Indoline derivatives substituted in the 6 position, their preparation and their use as medicaments
09/14/2005CN1668588A Indole derivatives, method for preparing same and pharmaceutical compositions containing same
09/14/2005CN1668587A Indole derivatives and drugs containing the same
09/14/2005CN1668586A Method for preparing 13 5-triaminobenzene and hydrolyzing it into high-purity phloroglucinal
09/14/2005CN1668579A Benzamide or phenylacetamide derivatives useful as thyroid receptor ligands
09/14/2005CN1668576A Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
09/14/2005CN1668575A Tgents and methods for the treatment of disorders associated with oxidative stress
09/14/2005CN1668561A Remedy
09/14/2005CN1668337A Agents for gene therapeutic for cerebrovascular disorders
09/14/2005CN1668333A Stable pharmaceutical composition comprising erythropoietin
09/14/2005CN1668327A Transdermal botulinum toxin compositions
09/14/2005CN1668316A Anti-spasmodic comprising xenon
09/14/2005CN1668315A Anti-spasmodic comprising xenon
09/14/2005CN1668313A Medicinal composition for drug-induced neuropathy
09/14/2005CN1668310A Hormone replacement therapy using a combination of conjugated estrogens and trimegestone
09/14/2005CN1668309A Trimegestone and estrogens for treating post menopausal disorders
09/14/2005CN1668296A Methods and compositions using selective cytokine inhibitory drugs for treatment and management of cancers and other diseases
09/14/2005CN1668294A Use of nefopam for the treatment of nausea or emesis
09/14/2005CN1668291A Substituted phenylsulfonamide inhibitors of beta amyloid production
09/14/2005CN1668289A Modafinil pharmaceutical compositions
09/14/2005CN1668284A Sustained release oral dosage forms of gabapentin
09/14/2005CN1668213A Ketoprofen-supplemented animal feed and use thereof in the simultaneous treatment of a group of animals for processes which are accompanied by fever, inflammation and/or pain
09/14/2005CN1666985A Medical use of andrographolidume and its derivatives and analogs
09/14/2005CN1666777A Medicinal preparation of brain protolysate for injection and preparation method thereof
09/14/2005CN1666772A Intelligence-developing, heart-nourishing, mind-tranquilizing and digestion-aiding oral liquid
09/14/2005CN1666749A Application of lucid ganoderma polysaccharide and spine date seed total flavone in preparing process of hypnotic and health caring product
09/14/2005CN1666741A Stable naloxone freeze dried powder injection and preparation technology thereof
09/14/2005CN1666740A Application of tetrandrine and Fangchinoline in preparation of medicine for improving sleep and health products
09/14/2005CN1666736A Compound Tramadol Hydrochoride dispersible Tablet
09/14/2005CN1218943C 4-pyrimidine-N-acyl-L-phenylalanines compound
09/14/2005CN1218941C Process for preparing ethyl-sulfonylpiperidine derivatives
09/14/2005CN1218940C Nitric oxide synthase inhibitors
09/14/2005CN1218936C Carboxamide-substituted phenylurea derivatives, process for their preparation and their use as medicaments
09/14/2005CN1218728C Chinese traditional medicine composition for treating epilepsy
09/13/2005US6943251 Preparation of salts of 4-[4-[(1R)-[4-(trifluoromethyl)phenyl]-2-methoxyethyl]-(3S)-methyl-1-piperazinyl]-4-methyl-1-[(4,6-dimethyl-5-pyrimidinyl)carbonyl]
09/13/2005US6943199 Eating disorders; psychological disorders; antidiabetic agents; cardiovascular disorders
09/13/2005US6943188 For manufacture of medicament for use in treating asthma, multiple sclerosis, inflammatory disease
09/13/2005US6943184 For therapy of Alzheimer's disease, Parkinson's disease, Pick's disease, Korsakoff s disease cerebral ageing, of mood disorders, of pain and of tobacco withdrawal
09/13/2005US6943182 Cyclopentabenzofuran derivatives and their use
09/13/2005US6943181 Use of substituted gamma-lactone compounds as pharmaceutical preparations
09/13/2005US6943180 Substituted N-arylsulfonyl-proline derivatives as potent cell adhesion inhibitors
09/13/2005US6943176 Heterocyclic derivatives
09/13/2005US6943173 Treatment of a number of CNS and periphereal disorders, particularly stress, anxiety, depression, cardiovascular disorders, and eating disorders.
09/13/2005US6943172 Antitumor agents; anticancer agents; sexual disorders; cardiovascular disorders
09/13/2005US6943167 Helix mimetics and composition and methods related thereto
09/13/2005US6943160 Morpholine derivatives as antagonists of orexin receptors
09/13/2005US6943158 for treating a fibroblast growth factor receptors (FGFR) kinase mediated disorder such as atherosclerosis
09/13/2005US6943016 incubating a mixture of astrocytes and glial cells from patient surgical resection, culturing, astrocytes joining to the culture vessel, removing the un-attached cells; purification; treating CNS trauma, neurodegenerative disorders
09/13/2005US6943000 Detection of modulator of enzyme activity; obtain cells, incubate with modulator, monitor adjustment in enzyme activity, adjustment in activity indicates modulator
09/13/2005US6942992 Nucleic acid sequences encoding human slit-, megf-, and roundabout-like polypeptides
09/13/2005US6942982 FEBP1 protein vector host cells and method for making FEBP1 protein
09/13/2005US6942979 Method for screening substances capable of modulating the activity of a TRAAK potassium channel
09/13/2005CA2469019C Pharmaceutical composition comprising a 5ht1 receptor agonist
09/13/2005CA2371583C Piperazine derivatives useful as ccr5 antagonists
09/13/2005CA2317462C 4-(2-keto-1-benzimidazolinyl)piperidine compounds as orl1-receptor agonists
09/13/2005CA2314896C A method of preventing abuse of opioid dosage forms
09/13/2005CA2314893C Opioid agonist/antagonist combinations
09/13/2005CA2292927C New imidazolin compounds, the process for preparing them and the pharmaceutical compositions that contain them
09/13/2005CA2210022C Paroxetine hydrochloride solvates
09/13/2005CA2179634C 4-arylisoindole analgesics
09/13/2005CA2078700C Imidazolylmethyl-pyridines
09/09/2005WO2005082905A1 Bicyclic heterocyclic compound
09/09/2005WO2005082887A1 Pyrimidine derivative
09/09/2005WO2005082865A1 Fused bicyclic pyrimidine derivative
09/09/2005WO2005082860A1 Tetracyclines and their use as calpain inhibitors
09/09/2005WO2005082855A1 Novel pyridine derivative and pyrimidine derivative (2)
09/09/2005WO2005082854A1 Novel pyridine derivative and pyrimidine derivative (1)
09/09/2005WO2005082847A1 Bicyclo derivative
09/09/2005WO2005082845A1 Novel therapies with somatostatin receptor agonists
09/09/2005WO2005082844A1 Treatment of diseases by using a somatostatin receptor agonist
09/09/2005WO2005082351A1 Therapeutic agent for neurodegenerative disorder
09/09/2005WO2005082135A1 Axon regenration promoter
09/09/2005WO2005081613A2 Pharmaceutical compositions of peptides secreted by the venom glands of snakes
09/09/2005WO2005014584A8 3-(indol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones,3-(benzimidazol-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones, and 3-(indolin-1-yl)-4-(indol-3-yl)-pyrrole-2,5-diones; their preparation and use as modulators of apoptosis
09/09/2005WO2004074232A8 1-phenylalkanecarboxylic acid derivatives for the treatment of neurodegenerative diseases
09/09/2005WO2003057854A3 Novel proteins and nucleic acids encoding same
1 ... 943 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 ... 1833